[Image: Company Logo]
Stock Code: 002213 Stock Abbreviation: Dawei Shares
Shenzhen Dawei Innovation Technology Co., Ltd.
2026 Prospectus for Issuance of Shares to Specific Targets via Simplified Procedure (Registration Draft)
Sponsor (Lead Underwriter): China Merchants Securities
July 2026
Statement
-
The Company and all members of the Board of Directors guarantee the authenticity, accuracy, and completeness of the contents of this prospectus, ensuring there are no false records, misleading statements, or major omissions, and assume individual and joint legal liability for any such instances.
-
This prospectus is prepared in accordance with the "Administrative Measures for the Registration of Securities Issuance by Listed Companies," the "Guidelines for Information Disclosure and Format of Securities Issuance by Listed Companies No. 61 - Prospectus and Issuance Report for Issuance of Securities to Specific Targets by Listed Companies," and other requirements.
-
Upon completion of this issuance of shares to specific targets via the simplified procedure, the Company is solely responsible for changes in its operations and earnings; investors are solely responsible for investment risks arising from this issuance.
-
This prospectus is the Board of Directors' explanation of this issuance; any contrary statements are false.
-
Investors with any questions should consult their stockbrokers, lawyers, professional accountants, or other professional advisors.
-
The matters stated in this prospectus do not represent a substantive judgment, confirmation, approval, or registration consent by the approval authorities regarding the matters related to this issuance.
Important Matters Notice
The Company reminds investors to pay attention to the following important matters or risk factors and to carefully read "Section VI: Risk Factors Related to This Issuance" in this prospectus.
I. On April 24, 2025, the Company held the 26th meeting of the 6th Board of Directors, which deliberated and approved the "Proposal on Requesting the General Meeting of Shareholders to Authorize the Board of Directors to Handle Matters Related to Small-Scale Rapid Financing."
On May 15, 2025, the Company held the 2024 Annual General Meeting of Shareholders, which deliberated and approved the "Proposal on Requesting the General Meeting of Shareholders to Authorize the Board of Directors to Handle Matters Related to Small-Scale Rapid Financing."
On March 9, 2026, the Company held the 32nd meeting of the 6th Board of Directors, which deliberated and approved the "Proposal on the Company's 2026 Plan for Issuance of Shares to Specific Targets via Simplified Procedure" and other related proposals.
On June 5, 2026, the Company held the 35th meeting of the 6th Board of Directors, which deliberated and approved the "Proposal on Extending the Validity Period of Resolutions and Authorizations Related to the Company's 2025 Issuance of Shares to Specific Targets via Simplified Procedure," and submitted it to the 2025 Annual General Meeting of Shareholders for deliberation.
On June 22, 2026, the 36th meeting of the 6th Board of Directors deliberated and approved the specific plan regarding the issuance price, quantity, and targets.
On June 26, 2026, the Company held the 2025 Annual General Meeting of Shareholders, which deliberated and approved the "Proposal on Extending the Validity Period of Resolutions and Authorizations Related to the Company's 2025 Issuance of Shares to Specific Targets via Simplified Procedure."
The matters related to this issuance have been reviewed and approved by the Shenzhen Stock Exchange's issuance and listing review body and have obtained the "Reply on Agreeing to the Registration of Shares Issued to Specific Targets by Shenzhen Dawei Innovation Technology Co., Ltd." (Zheng Jian Xu Ke [2026] No. 1710) issued by the CSRC. The Company will apply to the Shenzhen Stock Exchange and the Shenzhen Branch of China Securities Depository and Clearing Corporation for the issuance, registration, and listing of the shares to complete all reporting and approval procedures.